← FDA DRUG APPROVALS

FDA ANDA · ANDA078261

HYDROMORPHONE HYDROCHLORIDE

Sponsor: RISING

APPLICATION
ANDA078261
TYPE
ANDA
ORIGINAL APPROVAL
2010-04-14
LATEST ACTION
2025-04-24
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

HYDROMORPHONE HYDROCHLORIDEPrescription
HYDROMORPHONE HYDROCHLORIDE 10MG/ML · INJECTABLE · INJECTION

Approval history

2025-04-24Labeling · Supplement 12 · standardAP
2020-05-20Labeling · Supplement 7 · standardAP
2020-05-20Labeling · Supplement 4 · standardAP
2015-02-04Labeling · Supplement 2 · standardAP
2010-04-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →